Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Net Income (2022 - 2025)

Envoy Medical's Net Income history spans 4 years, with the latest figure at -$6.4 million for Q4 2025.

  • Quarterly results put Net Income at -$6.4 million for Q4 2025, down 29.43% from a year ago — trailing twelve months through Dec 2025 was -$23.9 million (down 18.87% YoY), and the annual figure for FY2025 was -$23.9 million, down 18.87%.
  • Net Income for Q4 2025 was -$6.4 million at Envoy Medical, down from -$6.2 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $12.5 million in Q1 2022 to a low of -$6.7 million in Q4 2023.
  • The 4-year median for Net Income is -$4.9 million (2024), against an average of -$2.2 million.
  • Peak annual rise in Net Income hit 26.63% in 2024, while the deepest fall reached 785.52% in 2024.
  • Year by year, Net Income stood at -$2.0 million in 2022, then crashed by 234.69% to -$6.7 million in 2023, then increased by 26.63% to -$4.9 million in 2024, then decreased by 29.43% to -$6.4 million in 2025.
  • According to Business Quant data, Net Income over the past three periods came in at -$6.4 million, -$6.2 million, and -$5.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.